Zobrazeno 81 - 90
of 111
pro vyhledávání: '"Tomoya Maeda"'
Autor:
Tomoya Maeda, Nozomi Niitsu
Publikováno v:
Internal medicine (Tokyo, Japan). 45(6)
Autor:
Naoki, Wakimoto, Motohiro, Misumi, Tomoya, Maeda, Tsuneyuki, Shimada, Daisuke, Wakao, Yasutaka, Sato, Naoki, Takahashi, Yuichi, Sugahara, Katsuhiko, Yoshida, Fumiharu, Yagasaki, Yuichi, Nakamura, Nobutaka, Kawai, Akira, Matsuda, Hidekazu, Kayano, Itsuro, Jinnai, Masami, Bessho
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 46(6)
A 62-year-old woman was admitted to our hospital because of gastric mucosal bleeding. Gastroendoscopy revealed a gastric tumor which was diagnosed from the biopsied specimen as diffuse large B-cell lymphoma (DLBCL). Lymphoma cells had infiltrated the
Autor:
Naoki, Wakimoto, Motohiro, Misumi, Tomoya, Maeda, Tsuneyuki, Shimada, Daisuke, Wakao, Yasutaka, Sato, Naoki, Takahashi, Yuichi, Sugahara, Katsuhiko, Yoshida, Fumiharu, Yagasaki, Yoshihiro, Ito, Yuichi, Nakamura, Nobutaka, Kawai, Akira, Matsuda, Itsuro, Jinnai, Masami, Bessho
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 46(7)
A 61-year-old man with primary macroglobulinemia (PMG) had been followed without any treatment as he had no apparent manifestations. After 1 year and 3 months, he was admitted to our hospital with a fever. No signs or symptoms of infection and no pro
Autor:
Isamu Sugiura, Kazunori Ohnishi, Nobuaki Dobashi, Yasushi Miyazaki, Tomoya Maeda, Kiyotoshi Imai, Keitaro Matsuo, Shuichi Mizuta, Yasutaka Aoyama, Hideki Akiyama, Tomoki Naoe, Yoshihiro Hatta, Shin Fujisawa, Kazuhiko Kakihana, Yasunori Ueda, Yasushi Onishi, Shigeki Ohtake
Publikováno v:
Blood. 124:932-932
Introduction: The outcome of BCR–ABL positive acute lymphoblastic leukemia (ALL) has drastically improved since the introduction of imatinib. We recently reported the clinical results of the Japan Adult Leukemia Study Group (JALSG) ALL-202 study at
Publikováno v:
The Proceedings of Conference of Kyushu Branch. 2013:193-194
Publikováno v:
Blood. 105(5)
We previously reported a novel fusion between TEL and FGFR3 in a patient with peripheral T-cell lymphoma with t(4; 12)(p16;p13). Disease in this patient subsequently progressed to acute myelogenous leukemia (AML) with the same translocation. Sequence
Autor:
Yasushi Miyazaki, Yoshihiro Hatta, Toru Sakura, Noriyoshi Iriyama, Hiroshi Handa, Masatomo Takahashi, Hisashi Sakamaki, Tomohiko Taki, Norio Asou, Shunichiro Yamaguchi, Tomoya Maeda, Shinya Satou, Shuichi Miyawaki, Sumihisa Honda, Shigeki Ohtake, Tomoki Naoe, Masafumi Taniwaki
Publikováno v:
Blood. 122:2608-2608
Background Immunophenotyping is a standard diagnostic procedure in leukemia, but unlike cytogenetic classifications, which are reliable indicators for prognostic interpretation, immunophenotyping has, thus far, yielded inconsistent results. Recently,
Autor:
Masao Tomonaga, Kengo Fuchigami, Hiroyuki Mori, Kazutaka Kuriyama, Hideki Nakamura, Tomoya Maeda, T. Kohno, K. Nagai, K. Izumikawa
Publikováno v:
European Journal of Haematology. 55:59-60
Autor:
Jin Takeuchi, Masafumi Taniwaki, Yoshihiro Hatta, Yoshiaki Ogawa, Yasushi Miyazaki, Masatomo Takahashi, Tomoki Naoe, Toru Sakura, Tohru Izumi, Fumihiro Ishida, Hisashi Sakamaki, Shigeki Ohtake, Shuichi Miyawaki, Tomoya Maeda, Sumihisa Honda, Noriyoshi Iriyama, Kinuko Mitani, Tomohiko Taki
Publikováno v:
Blood. 120:2511-2511
Abstract 2511 Background: Although prognosis of acute myeloid leukemia (AML) with t(8;21) is better than other types of AML, outcome of the patients has not been satisfied. Previously, aberrant antigen expression has been reported as risk factor for
Autor:
Satoru Takada, Yoshifusa Takatsuka, Kiyotoshi Imai, Yukihiko Kimura, Yukiyoshi Moriuchi, Yasushi Miyazaki, Keitaro Matsuo, Noriko Usui, Shuichi Mizuta, Tomoya Maeda, Sigehisa Tamaki, Hideki Akiyama, Toshiaki Yujiri, Akira Yokota, Heiwa Kanamori, Kazunori Ohnishi, Shigeki Ohtake, Yoshihiro Hatta, Tomoki Naoe, Yasunori Ueda
Publikováno v:
Blood Cancer Journal
We investigated prognostic factors for the clinical outcome of allogeneic hematopoietic stem cell transplantation (allo-HSCT) in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL) following imatinib-based therapy. Am